En este Endotips presentamos las revisiones mas recientes sobre el sistema renina angiotensina y sus implicaciones sobre el metabolismo.
- Novel RAAS agonists and antagonists: clinical applications and controversies. Romero CA, Orias M, Weir MR. Nat Rev Endocrinol. 2015 Apr;11(4):242-52. PDF
- New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D. Etelvino GM, Peluso AA, Santos RA. Curr Hypertens Rep. 2014 Jun;16(6):433 PDF
- Angiotensins as therapeutic targets beyond heart disease. Passos-Silva DG, Brandan E, Santos RA. Trends Pharmacol Sci. 2015 May;36(5):310-20 PDF
- Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets. Jiang F, Yang J, Zhang Y, Dong M, Wang S, Zhang Q, Liu FF, Zhang K, Zhang C. Nat Rev Cardiol. 2014 Jul;11(7):413-26. PDF
- Angiotensin converting enzyme 2: a new important player in the regulation of glycemia. Chhabra KH, Chodavarapu H, Lazartigues E. IUBMB Life. 2013 Sep;65(9):731-8. PDF
- Modulation of the action of insulin by angiotensin-(1-7). Dominici FP, Burghi V, Muñoz MC, Giani JF. Clin Sci (Lond). 2014 May;126(9):613-30. PDF
